{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:52:10Z","timestamp":1791136330635,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":91,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540921646","type":"print"},{"value":"9783540921653","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-92165-3_12","type":"book-chapter","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T10:32:36Z","timestamp":1253269956000},"page":"227-241","source":"Crossref","is-referenced-by-count":37,"title":["Influenza Neuraminidase as a Vaccine Antigen"],"prefix":"10.1007","author":[{"given":"Matthew J.","family":"Sylte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"issue":"4","key":"12_CR1_12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jmv.10143","volume":"67","author":"Y Abed","year":"2002","unstructured":"Abed Y et al (2002) Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada. J Med Virol 67(4):589\u2013595","journal-title":"J Med Virol"},{"issue":"1","key":"12_CR2_12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/jac\/dkg007","volume":"51","author":"FY Aoki","year":"2003","unstructured":"Aoki FY et al (2003) Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 51(1):123\u2013129","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 2","key":"12_CR3_12","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/S0264-410X(02)00133-0","volume":"20","author":"M Aymard","year":"2002","unstructured":"Aymard M (2002) Quantification of neuramidase (NA) protein content. Vaccine 20(suppl 2):S59\u2013S60","journal-title":"Vaccine"},{"issue":"1","key":"12_CR4_12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0042-6822(91)90003-T","volume":"180","author":"LG Baum","year":"1991","unstructured":"Baum LG, Paulson JC (1991) The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity. Virology 180(1):10\u201315","journal-title":"Virology"},{"issue":"2","key":"12_CR5_12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF01315002","volume":"70","author":"C Bottex","year":"1981","unstructured":"Bottex C, Burckhart MF, Fontanges R (1981) Comparative immunogenicity of live influenza viruses and their solubilized neuraminidases: results of mouse protection experiments. Arch Virol 70(2):83\u201389","journal-title":"Arch Virol"},{"key":"12_CR6_12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1743-422X-5-40","volume":"5","author":"K Bragstad","year":"2008","unstructured":"Bragstad K, Nielsen LP, Fomsgaard A (2008) The evolution of human influenza A viruses from 1999 to 2006: a complete genome study. Virol J 5:40","journal-title":"Virol J"},{"issue":"2","key":"12_CR7_12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.virol.2005.06.006","volume":"339","author":"IC Brett","year":"2005","unstructured":"Brett IC, Johansson BE (2005) Immunization against influenza A virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology 339(2):273\u2013280","journal-title":"Virology"},{"issue":"3","key":"12_CR8_12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/jb\/mvj051","volume":"139","author":"IC Brett","year":"2006","unstructured":"Brett IC, Johansson BE (2006) Variation in the divalent cation requirements of influenza A virus N1 neuraminidases. J Biochem 139(3):439\u2013447","journal-title":"J Biochem"},{"issue":"2","key":"12_CR9_12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1006\/viro.1993.1088","volume":"192","author":"WP Burmeister","year":"1993","unstructured":"Burmeister WP et al (1993) Comparison of structure and sequence of influenza B\/Yamagata and B\/Beijing neuraminidases shows a conserved \u201chead\u201d but much greater variability in the \u201cstalk\u201d and NB protein. Virology 192(2):683\u2013686","journal-title":"Virology"},{"issue":"34","key":"12_CR10_12","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1016\/j.vaccine.2005.03.035","volume":"23","author":"J Chen","year":"2005","unstructured":"Chen J et al (2005) Protection against influenza virus infection in BALB\/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. Vaccine 23(34):4322\u20134328","journal-title":"Vaccine"},{"issue":"16","key":"12_CR11_12","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/S0264-410X(98)00043-7","volume":"16","author":"Z Chen","year":"1998","unstructured":"Chen Z et al (1998) Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine 16(16):1544\u20131549","journal-title":"Vaccine"},{"issue":"7\u20138","key":"12_CR12_12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0264-410X(98)00247-3","volume":"17","author":"Z Chen","year":"1999","unstructured":"Chen Z et al (1999a) Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 17(7\u20138):653\u2013659","journal-title":"Vaccine"},{"issue":"Pt 10","key":"12_CR13_12","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1099\/0022-1317-80-10-2559","volume":"80","author":"Z Chen","year":"1999","unstructured":"Chen Z et al (1999b) Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein. J Gen Virol 80(Pt 10):2559\u20132564","journal-title":"J Gen Virol"},{"issue":"28","key":"12_CR14_12","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1016\/S0264-410X(00)00149-3","volume":"18","author":"Z Chen","year":"2000","unstructured":"Chen Z et al (2000) Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 18(28):3214\u20133222","journal-title":"Vaccine"},{"key":"12_CR15_12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-4613-0811-9_4","volume-title":"Neuraminidase enzyme and antigen, in the influenza viruses","author":"PM Colman","year":"1989","unstructured":"Colman PM (1989) In: Krug RM (ed) Neuraminidase enzyme and antigen, in the influenza viruses. Plenum, New York, pp 175\u2013218"},{"issue":"5912","key":"12_CR16_12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/303041a0","volume":"303","author":"PM Colman","year":"1983","unstructured":"Colman PM, Varghese JN, Laver WG (1983) Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303(5912):41\u201344","journal-title":"Nature"},{"issue":"10","key":"12_CR17_12","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/sj.gt.3301004","volume":"6","author":"P Colmenero","year":"1999","unstructured":"Colmenero P, Liljestrom P, Jondal M (1999) Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene. Gene Ther 6(10):1728\u20131733","journal-title":"Gene Ther"},{"issue":"25","key":"12_CR18_12","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa054512","volume":"353","author":"MD de Jong","year":"2005","unstructured":"de Jong MD et al (2005) Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353(25):2667\u20132672","journal-title":"N Engl J Med"},{"issue":"6","key":"12_CR19_12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/0264-410X(95)00157-V","volume":"14","author":"T Deroo","year":"1996","unstructured":"Deroo T, Jou WM, Fiers W (1996) Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine 14(6):561\u2013569","journal-title":"Vaccine"},{"issue":"1","key":"12_CR20_12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0042-6822(85)90226-0","volume":"147","author":"KL Deshpande","year":"1985","unstructured":"Deshpande KL, Naeve CW, Webster RG (1985) The neuraminidases of the virulent and avirulent A\/Chicken\/Pennsylvania\/83 (H5N2) influenza A viruses: sequence and antigenic analyses. Virology 147(1):49\u201360","journal-title":"Virology"},{"issue":"3","key":"12_CR21_12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4049\/jimmunol.105.3.620","volume":"105","author":"JC Downie","year":"1970","unstructured":"Downie JC (1970) Neuraminidase- and hemagglutinin-inhibiting antibodies in serum and nasal secretions of volunteers immunized with attenuated and inactivated influenza B-Eng-13\u201365 virus vaccines. J Immunol 105(3):620\u2013626","journal-title":"J Immunol"},{"issue":"12","key":"12_CR22_12","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.4049\/jimmunol.150.12.5484","volume":"150","author":"SL Epstein","year":"1993","unstructured":"Epstein SL et al (1993) Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J Immunol 150(12):5484\u20135493","journal-title":"J Immunol"},{"issue":"15","key":"12_CR23_12","doi-asserted-by":"publisher","first-page":"8597","DOI":"10.1073\/pnas.96.15.8597","volume":"96","author":"KJ Flynn","year":"1999","unstructured":"Flynn KJ et al (1999) In vivo proliferation of naive and memory influenza-specific CD8(+) T cells. Proc Natl Acad Sci USA 96(15):8597\u20138602","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"12_CR24_12","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1128\/JVI.80.4.1959-1964.2006","volume":"80","author":"W Gao","year":"2006","unstructured":"Gao W et al (2006) Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 80(4):1959\u20131964","journal-title":"J Virol"},{"key":"12_CR25_12","first-page":"189","volume":"98","author":"L Gerentes","year":"1999","unstructured":"Gerentes L, Kessler N, Aymard M (1999) Difficulties in standardizing the neuraminidase content of influenza vaccines. Dev Biol Stand 98:189\u2013196; discussion 197","journal-title":"Dev Biol Stand"},{"issue":"3","key":"12_CR26_12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/0006-3002(57)90389-X","volume":"23","author":"A Gottschalk","year":"1957","unstructured":"Gottschalk A (1957) Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae. Biochim Biophys Acta 23(3):645\u2013646","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"12_CR27_12","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1128\/AAC.01312-06","volume":"51","author":"EA Govorkova","year":"2007","unstructured":"Govorkova EA et al (2007) Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob Agents Chemother 51(4):1414\u20131424","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"12_CR28_12","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood.V87.8.3450.bloodjournal8783450","volume":"87","author":"KL Hartshorn","year":"1996","unstructured":"Hartshorn KL et al (1996) Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. Blood 87(8):3450\u20133461","journal-title":"Blood"},{"issue":"5","key":"12_CR29_12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/infdis\/148.5.785","volume":"148","author":"G Hashimoto","year":"1983","unstructured":"Hashimoto G, Wright PF, Karzon DT (1983) Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J Infect Dis 148(5):785\u2013794","journal-title":"J Infect Dis"},{"issue":"9","key":"12_CR30_12","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1086\/424572","volume":"190","author":"ML Herlocher","year":"2004","unstructured":"Herlocher ML et al (2004) Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis 190(9):1627\u20131630","journal-title":"J Infect Dis"},{"issue":"3","key":"12_CR31_12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.antiviral.2007.08.002","volume":"76","author":"HT Ho","year":"2007","unstructured":"Ho HT et al (2007) Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues. Antiviral Res 76(3):263\u2013266","journal-title":"Antiviral Res"},{"issue":"15\u201316","key":"12_CR32_12","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0264-410X(98)00413-7","volume":"17","author":"BE Johansson","year":"1999","unstructured":"Johansson BE (1999) Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Vaccine 17(15\u201316):2073\u20132080","journal-title":"Vaccine"},{"issue":"10","key":"12_CR33_12","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/JVI.67.10.5721-5723.1993","volume":"67","author":"BE Johansson","year":"1993","unstructured":"Johansson BE, Kilbourne ED (1993) Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition. J Virol 67(10):5721\u20135723","journal-title":"J Virol"},{"issue":"6","key":"12_CR34_12","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.139.6.2015","volume":"139","author":"BE Johansson","year":"1987","unstructured":"Johansson BE et al (1987a) Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice. J Immunol 139(6):2015\u20132019","journal-title":"J Immunol"},{"issue":"6","key":"12_CR35_12","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.139.6.2010","volume":"139","author":"BE Johansson","year":"1987","unstructured":"Johansson BE et al (1987b) Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience. J Immunol 139(6):2010\u20132014","journal-title":"J Immunol"},{"issue":"19","key":"12_CR36_12","doi-asserted-by":"publisher","first-page":"6869","DOI":"10.1073\/pnas.84.19.6869","volume":"84","author":"BE Johansson","year":"1987","unstructured":"Johansson BE, Moran TM, Kilbourne ED (1987c) Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins. Proc Natl Acad Sci USA 84(19):6869\u20136873","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"12_CR37_12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1128\/JVI.63.3.1239-1246.1989","volume":"63","author":"BE Johansson","year":"1989","unstructured":"Johansson BE, Bucher DJ, Kilbourne ED (1989) Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J Virol 63(3):1239\u20131246","journal-title":"J Virol"},{"issue":"10","key":"12_CR38_12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/0264-410X(93)90130-P","volume":"11","author":"BE Johansson","year":"1993","unstructured":"Johansson BE, Grajower B, Kilbourne ED (1993) Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice. Vaccine 11(10):1037\u20131039","journal-title":"Vaccine"},{"issue":"9","key":"12_CR39_12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0264-410X(94)00071-T","volume":"13","author":"BE Johansson","year":"1995","unstructured":"Johansson BE, Price PM, Kilbourne ED (1995) Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants. Vaccine 13(9):841\u2013845","journal-title":"Vaccine"},{"issue":"9\u201310","key":"12_CR40_12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0264-410X(97)00279-X","volume":"16","author":"BE Johansson","year":"1998","unstructured":"Johansson BE, Matthews JT, Kilbourne ED (1998) Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. Vaccine 16(9\u201310):1009\u20131015","journal-title":"Vaccine"},{"issue":"11\u201312","key":"12_CR41_12","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0264-410X(01)00490-X","volume":"20","author":"BE Johansson","year":"2002","unstructured":"Johansson BE, Pokorny BA, Tiso VA (2002) Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition. Vaccine 20(11\u201312):1670\u20131674","journal-title":"Vaccine"},{"issue":"1","key":"12_CR42_12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1128\/IAI.8.1.130-131.1973","volume":"8","author":"JA Kasel","year":"1973","unstructured":"Kasel JA et al (1973) Effect of influenza anti-neuraminidase antibody on virus neutralization. Infect Immun 8(1):130\u2013131","journal-title":"Infect Immun"},{"issue":"1","key":"12_CR43_12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0042-6822(88)90260-7","volume":"163","author":"Y Kawaoka","year":"1988","unstructured":"Kawaoka Y et al (1988) Is the gene pool of influenza viruses in shorebirds and gulls different from that in wild ducks? Virology 163(1):247\u2013250","journal-title":"Virology"},{"key":"12_CR44_12","doi-asserted-by":"crossref","first-page":"S415","DOI":"10.1093\/infdis\/136.Supplement_3.S415","volume":"136","author":"AP Kendal","year":"1977","unstructured":"Kendal AP, Noble GR, Dowdle WR (1977) Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. J Infect Dis 136(suppl):S415\u2013S424","journal-title":"J Infect Dis"},{"issue":"4","key":"12_CR45_12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/JVI.2.4.281-288.1968","volume":"2","author":"ED Kilbourne","year":"1968","unstructured":"Kilbourne ED et al (1968a) Antiviral activity of antiserum specific for an influenza virus neuraminidase. J Virol 2(4):281\u2013288","journal-title":"J Virol"},{"issue":"7","key":"12_CR46_12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/JVI.2.7.761-762.1968","volume":"2","author":"ED Kilbourne","year":"1968","unstructured":"Kilbourne ED, Christenson WN, Sande M (1968b) Antibody response in man to influenza virus neuraminidase following influenza. J Virol 2(7):761\u2013762","journal-title":"J Virol"},{"issue":"2","key":"12_CR47_12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1073\/pnas.87.2.786","volume":"87","author":"ED Kilbourne","year":"1990","unstructured":"Kilbourne ED, Johansson BE, Grajower B (1990) Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. Proc Natl Acad Sci USA 87(2):786\u2013790","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"12_CR48_12","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/0264-410X(95)00127-M","volume":"13","author":"ED Kilbourne","year":"1995","unstructured":"Kilbourne ED et al (1995) Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans. Vaccine 13(18):1799\u20131803","journal-title":"Vaccine"},{"issue":"3","key":"12_CR49_12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1086\/381123","volume":"189","author":"ED Kilbourne","year":"2004","unstructured":"Kilbourne ED et al (2004) Protection of mice with recombinant influenza virus neuraminidase. J Infect Dis 189(3):459\u2013461","journal-title":"J Infect Dis"},{"issue":"9436","key":"12_CR50_12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","volume":"364","author":"M Kiso","year":"2004","unstructured":"Kiso M et al (2004) Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364(9436):759\u2013765","journal-title":"Lancet"},{"issue":"8","key":"12_CR51_12","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1128\/JVI.73.8.6743-6751.1999","volume":"73","author":"D Kobasa","year":"1999","unstructured":"Kobasa D et al (1999) Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase. J Virol 73(8):6743\u20136751","journal-title":"J Virol"},{"issue":"7062","key":"12_CR52_12","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/4371108a","volume":"437","author":"QM Le","year":"2005","unstructured":"Le QM et al (2005) Avian flu: isolation of drug-resistant H5N1 virus. Nature 437(7062):1108","journal-title":"Nature"},{"issue":"15","key":"12_CR53_12","doi-asserted-by":"publisher","first-page":"8372","DOI":"10.1128\/JVI.78.15.8372-8381.2004","volume":"78","author":"CW Lee","year":"2004","unstructured":"Lee CW, Senne DA, Suarez DL (2004) Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 78(15):8372\u20138381","journal-title":"J Virol"},{"issue":"suppl 1","key":"12_CR54_12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1637\/7548-033106R.1","volume":"51","author":"YJ Lee","year":"2007","unstructured":"Lee YJ et al (2007) Effects of homologous and heterologous neuraminidase vaccines in chickens against H5N1 highly pathogenic avian influenza. Avian Dis 51(suppl 1):476\u2013478","journal-title":"Avian Dis"},{"issue":"4","key":"12_CR55_12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/dna.2006.25.197","volume":"25","author":"X Li","year":"2006","unstructured":"Li X et al (2006) Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection. DNA Cell Biol 25(4):197\u2013205","journal-title":"DNA Cell Biol"},{"issue":"2","key":"12_CR56_12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/JVI.69.2.1099-1106.1995","volume":"69","author":"C Liu","year":"1995","unstructured":"Liu C et al (1995) Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol 69(2):1099\u20131106","journal-title":"J Virol"},{"issue":"1","key":"12_CR57_12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1432-1033.1997.00332.x","volume":"247","author":"W Martinet","year":"1997","unstructured":"Martinet W et al (1997) Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase. Eur J Biochem 247(1):332\u2013338","journal-title":"Eur J Biochem"},{"issue":"2","key":"12_CR58_12","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1128\/JVI.73.2.1146-1155.1999","volume":"73","author":"M Matrosovich","year":"1999","unstructured":"Matrosovich M et al (1999) The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol 73(2):1146\u20131155","journal-title":"J Virol"},{"issue":"22","key":"12_CR59_12","doi-asserted-by":"publisher","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","volume":"78","author":"MN Matrosovich","year":"2004","unstructured":"Matrosovich MN et al (2004) Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 78(22):12665\u201312667","journal-title":"J Virol"},{"issue":"1","key":"12_CR60_12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/03079458608436270","volume":"15","author":"M McNulty","year":"1986","unstructured":"McNulty M, Allan G, McKracken R (1986) Efficacy of avian influenza neuraminidase-specific vaccines in chickens. Avian Pathol 15(1):107\u2013115","journal-title":"Avian Pathol"},{"issue":"7","key":"12_CR61_12","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1128\/AAC.01339-05","volume":"50","author":"AS Monto","year":"2006","unstructured":"Monto AS et al (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50(7):2395\u20132402","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"12_CR62_12","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMra050740","volume":"353","author":"A Moscona","year":"2005","unstructured":"Moscona A (2005) Neuraminidase inhibitors for influenza. N Engl J Med 353(13):1363\u20131373","journal-title":"N Engl J Med"},{"issue":"2","key":"12_CR63_12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.virol.2006.05.008","volume":"352","author":"K Mozdzanowska","year":"2006","unstructured":"Mozdzanowska K et al (2006) Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components. Virology 352(2):418\u2013426","journal-title":"Virology"},{"issue":"25","key":"12_CR64_12","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","volume":"286","author":"BR Murphy","year":"1972","unstructured":"Murphy BR, Kasel JA, Chanock RM (1972) Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med 286(25):1329\u20131332","journal-title":"N Engl J Med"},{"issue":"Pt 3","key":"12_CR65_12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1099\/0022-1317-76-3-613","volume":"76","author":"K Nerome","year":"1995","unstructured":"Nerome K et al (1995) Genetic analysis of porcine H3N2 viruses originating in southern China. J Gen Virol 76(Pt 3): 613\u2013624","journal-title":"J Gen Virol"},{"issue":"2","key":"12_CR66_12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1006\/viro.2001.0992","volume":"286","author":"S Oh","year":"2001","unstructured":"Oh S, Belz GT, Eichelberger MC (2001) Viral neuraminidase treatment of dendritic cells enhances antigen-specific CD8(+) T cell proliferation, but does not account for the CD4(+) T cell independence of the CD8(+) T cell response during influenza virus infection. Virology 286(2):403\u2013411","journal-title":"Virology"},{"issue":"1","key":"12_CR67_12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/0307945021000070688","volume":"32","author":"CL Qiao","year":"2003","unstructured":"Qiao CL et al (2003) Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol 32(1):25\u201332","journal-title":"Avian Pathol"},{"issue":"5772","key":"12_CR68_12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1126\/science.1122947","volume":"312","author":"RR Regoes","year":"2006","unstructured":"Regoes RR, Bonhoeffer S (2006) Emergence of drug-resistant influenza virus: population dynamical considerations. Science 312(5772):389\u2013391","journal-title":"Science"},{"key":"12_CR69_12","first-page":"319","volume":"28","author":"E Reichert","year":"1975","unstructured":"Reichert E, Mauler R (1975) Effect of neuraminidase on potency of inactivated influenza virus vaccines in mice. Dev Biol Stand 28:319\u2013323","journal-title":"Dev Biol Stand"},{"issue":"1","key":"12_CR70_12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1099\/0022-1317-22-1-35","volume":"22","author":"R Rott","year":"1974","unstructured":"Rott R, Becht H, Orlich M (1974) The significance of influenza virus neuraminidase in immunity. J Gen Virol 22(1):35\u201341","journal-title":"J Gen Virol"},{"issue":"2","key":"12_CR71_12","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","volume":"4","author":"MR Sandbulte","year":"2006","unstructured":"Sandbulte MR et al (2006) Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4(2):e59. doi:10.1371\/journal.pmed.0040059","journal-title":"PLoS Med"},{"issue":"3","key":"12_CR72_12","first-page":"647","volume":"41","author":"JL Schulman","year":"1969","unstructured":"Schulman JL (1969) The role of antineuraminidase antibody in immunity to influenza virus infection. Bull World Health Organ 41(3):647\u2013650","journal-title":"Bull World Health Organ"},{"issue":"8","key":"12_CR73_12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/JVI.2.8.778-786.1968","volume":"2","author":"JL Schulman","year":"1968","unstructured":"Schulman JL, Khakpour M, Kilbourne ED (1968) Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol 2(8):778\u2013786","journal-title":"J Virol"},{"issue":"1","key":"12_CR74_12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2307\/1589250","volume":"18","author":"RD Slemons","year":"1974","unstructured":"Slemons RD et al (1974) Type-A influenza viruses isolated from wild free-flying ducks in California. Avian Dis 18(1):119\u2013124","journal-title":"Avian Dis"},{"issue":"Pt 6","key":"12_CR75_12","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1099\/0022-1317-66-6-1333","volume":"66","author":"L Stitz","year":"1985","unstructured":"Stitz L et al (1985) Cytotoxic T cell lysis of target cells fused with liposomes containing influenza virus haemagglutinin and neuraminidase. J Gen Virol 66(Pt 6):1333\u20131339","journal-title":"J Gen Virol"},{"issue":"2\u20133","key":"12_CR76_12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0145-305X(99)00078-6","volume":"24","author":"DL Suarez","year":"2000","unstructured":"Suarez DL, Schultz-Cherry S (2000) Immunology of avian influenza virus: a review. Dev Comp Immunol 24(2\u20133):269\u2013283","journal-title":"Dev Comp Immunol"},{"issue":"3","key":"12_CR77_12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1248\/bpb.28.399","volume":"28","author":"Y Suzuki","year":"2005","unstructured":"Suzuki Y (2005) Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 28(3):399\u2013408","journal-title":"Biol Pharm Bull"},{"issue":"19","key":"12_CR78_12","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1016\/j.vaccine.2007.02.011","volume":"25","author":"MJ Sylte","year":"2007","unstructured":"Sylte MJ, Hubby B, Suarez DL (2007) Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine 25(19):3763\u20133772","journal-title":"Vaccine"},{"issue":"37","key":"12_CR79_12","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1016\/j.vaccine.2005.04.042","volume":"23","author":"T Tanimoto","year":"2005","unstructured":"Tanimoto T, et al. (2005) Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography. Vaccine 23(37):4598\u20134609","journal-title":"Vaccine"},{"issue":"5912","key":"12_CR80_12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/303035a0","volume":"303","author":"JN Varghese","year":"1983","unstructured":"Varghese JN, Laver WG, Colman PM (1983) Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature 303(5912):35\u201340","journal-title":"Nature"},{"issue":"2","key":"12_CR81_12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1006\/viro.2000.0566","volume":"276","author":"O Vidalin","year":"2000","unstructured":"Vidalin O et al\u2009\u2009\u2009(2000) Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens. Virology 276(2):259\u2013270","journal-title":"Virology"},{"key":"12_CR82_12","first-page":"337","volume":"39","author":"V Vonka","year":"1977","unstructured":"Vonka V et al (1977) Small-scale field trial with neuraminidase vaccine. Dev Biol Stand 39:337\u2013339","journal-title":"Dev Biol Stand"},{"issue":"3","key":"12_CR83_12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1099\/0022-1317-3-3-315","volume":"3","author":"RG Webster","year":"1968","unstructured":"Webster RG, Laver WG, Kilbourne ED (1968) Reactions of antibodies with surface antigens of influenza virus. J Gen Virol 3(3):315\u2013326","journal-title":"J Gen Virol"},{"issue":"1","key":"12_CR84_12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0042-6822(88)90640-X","volume":"164","author":"RG Webster","year":"1988","unstructured":"Webster RG, Reay PA, Laver WG (1988) Protection against lethal influenza with neuraminidase. Virology 164(1):230\u2013237","journal-title":"Virology"},{"issue":"2","key":"12_CR85_12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","volume":"20","author":"RJ Whitley","year":"2001","unstructured":"Whitley RJ et al (2001) Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 20(2):127\u2013133","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"12_CR86_12","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.167.6.3293","volume":"167","author":"JA Wiley","year":"2001","unstructured":"Wiley JA et al (2001) Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection. J Immunol 167(6):3293\u20133299","journal-title":"J Immunol"},{"issue":"2","key":"12_CR87_12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/BF00731360","volume":"12","author":"G Xu","year":"1995","unstructured":"Xu G et al (1995) Sialidase of swine influenza A viruses: variation of the recognition specificities for sialyl linkages and for the molecular species of sialic acid with the year of isolation. Glycoconj J 12(2):156\u2013161","journal-title":"Glycoconj J"},{"issue":"1","key":"12_CR88_12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/viro.1996.0519","volume":"224","author":"X Xu","year":"1996","unstructured":"Xu X et al (1996) Genetic variation in neuraminidase genes of influenza A (H3N2) viruses. Virology 224(1):175\u2013183","journal-title":"Virology"},{"issue":"4","key":"12_CR89_12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1348-0421.2008.00034.x","volume":"52","author":"T Yano","year":"2008","unstructured":"Yano T et al (2008) Effects of single-point amino acid substitutions on the structure and function neuraminidase proteins in influenza A virus. Microbiol Immunol 52(4):216\u2013223","journal-title":"Microbiol Immunol"},{"issue":"17","key":"12_CR90_12","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.1128\/JVI.00477-06","volume":"80","author":"HL Yen","year":"2006","unstructured":"Yen HL et al (2006) Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses. J Virol 80(17):8787\u20138795","journal-title":"J Virol"},{"issue":"11","key":"12_CR91_12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1089\/dna.2005.24.758","volume":"24","author":"F Zhang","year":"2005","unstructured":"Zhang F et al (2005) Maternal immunization with both hemagglutinin- and neuraminidase-expressing DNAs provides an enhanced protection against a lethal influenza virus challenge in infant and adult mice. DNA Cell Biol 24(11):758\u2013765","journal-title":"DNA Cell Biol"}],"container-title":["Current Topics in Microbiology and Immunology","Vaccines for Pandemic Influenza"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-92165-3_12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T12:55:48Z","timestamp":1710593748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-92165-3_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540921646","9783540921653"],"references-count":91,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-92165-3_12","relation":{},"ISSN":["0070-217X"],"issn-type":[{"value":"0070-217X","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}